retatrutide phase 2 nejm weight loss 48 weeks triple agonist This data from 3 clinical trials for was announced yesterday at @amdiabetesassn #ADA2026 ✓ We are fortunate to be living in a time where there multiple medications which safely reduce Michael Weintraub, MD on X:

Common side effects include: Nausea and vomiting Diarrhoea or constipation Reduced appetite Abdominal discomfort or bloating Injection site reactions (redness, itching, or mild swelling) These effects can often be managed by eating smaller, lower-fat meals, avoiding lying down immediately after eating, staying well hydrated, and adhering to the gradual dose-escalation schedule

The consultation was very informative and thorough

doi: 10.1038/s41392-024-01769-5, 154 ZhouZ

Researchers have documented this distinction across the published mechanism literature

Compounded tirzepatide: Tirzepatide compounding has faced its own regulatory evolution